Figure 2.
Kaplan–Meier disease‐specific survival analysis of dedifferentiated/undifferentiated endometrial carcinomas stratified by SWI/SNF protein status in (A) the early stage setting (FIGO stage I and II) and (B) the advanced stage setting (FIGO stage III and IV) (gray‐colored line: SWI/SNF‐intact tumors; black‐colored line: SWI/SNF‐deficient tumors).